NDC 63850-0025

Letrozole

Letrozole

Letrozole is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Natco Pharma Limited. The primary component is Letrozole.

Product ID63850-0025_7917d6e0-df93-4c10-97c9-3d90b00b7bd4
NDC63850-0025
Product TypeHuman Prescription Drug
Proprietary NameLetrozole
Generic NameLetrozole
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-06-03
Marketing CategoryANDA / ANDA
Application NumberANDA200161
Labeler NameNatco Pharma Limited
Substance NameLETROZOLE
Active Ingredient Strength3 mg/1
Pharm ClassesAromatase Inhibitor [EPC],Aromatase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63850-0025-1

30 TABLET in 1 BOTTLE (63850-0025-1)
Marketing Start Date2011-06-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Letrozole" or generic name "Letrozole"

NDCBrand NameGeneric Name
0093-7620LetrozoleLetrozole
16729-034Letrozoleletrozole
17856-0032Letrozoleletrozole
24535-0801LETROZOLELETROZOLE
24724-030LETROZOLELETROZOLE
42254-243LetrozoleLetrozole
42291-374LetrozoleLetrozole
50090-3474Letrozoleletrozole
50268-476LETROZOLELETROZOLE
51991-759LETROZOLELETROZOLE
55111-646LetrozoleLetrozole
57884-2021LETROZOLELETROZOLE
59651-180LetrozoleLetrozole
60505-3255LetrozoleLetrozole
62135-491LETROZOLELetrozole
62756-511LETROZOLELETROZOLE
63629-7819Letrozoleletrozole
63850-0025LetrozoleLetrozole
65841-744letrozoleletrozole
68071-5264Letrozoleletrozole
68084-803LetrozoleLetrozole
68382-363letrozoleletrozole
69117-0004LetrozoleLetrozole Tablets
70518-1869LetrozoleLetrozole
70518-2020LetrozoleLetrozole
71335-1526LETROZOLELETROZOLE
0078-0249Femaraletrozole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.